Recently Viewed

News Announcement

Jenburkt Pharmaceuticals: Announcement under Regulation 30 (LODR)-Change in Directorate

04-Sep-2026 Follow Value Research Online on Google download pdfDownload PDF Jenburkt Pharma

Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April 2027 to 31st March 2032 Approved with requisite mejority by the shareholders at 41st AGM of the Company held today i.e. 04th September 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan